Profil
Marcel Frenkel is associated with Ten63 Therapeutics, Inc. as the Chief Executive Officer since 2020.
He is the founder of Ten63 Therapeutics, Inc. which was founded in 2020.
Postes actifs de Marcel Frenkel
| Sociétés | Poste | Début |
|---|---|---|
TEN63 Therapeutics
 TEN63 Therapeutics Pharmaceuticals: MajorHealth Technology TEN63 Therapeutics provides drug development services. The American company was founded by Nancy Miller-Rich, Marcel Frenkel, Mark Hallen, Bruce Donald. Marcel Frenkel has been the CEO since incorporation. | Directeur Général | 05/03/2020 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
TEN63 Therapeutics
TEN63 Therapeutics Pharmaceuticals: MajorHealth Technology TEN63 Therapeutics provides drug development services. The American company was founded by Nancy Miller-Rich, Marcel Frenkel, Mark Hallen, Bruce Donald. Marcel Frenkel has been the CEO since incorporation. | Health Technology |
